DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Performance 5 years - DRIO ranking 17 / 58

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by performance 5 years
1. Medpace Holdings MEDP
385.26
2. Lantheus Holdings LNTH
334.89
3. RadNet RDNT
275.95
4. Natera NTRA
259.64
5. Fulgent Genetics FLGT
219.24
6. Danaher DHR
122.54
7. Thermo Fisher Scientific TMO
121.61
8. Meridian Bioscience VIVO
118.46
9. Icon ICLR
105.66
10. Agilent Technologies A
101.16
11. Mettler-Toledo MTD
97.36
12. DexCom DXCM
93.94
13. Charles River Laboratories CRL
74.75
14. IDEXX Laboratories IDXX
74.28
15. Laboratory Corp of America Holdings LH
65.72
16. Waters WAT
63.14
17. DarioHealth DRIO
61.4
18. IQVIA Holdings IQV
53.05
19. PerkinElmer PKI
48.44
20. Quest Diagnostics DGX
48.11
21. Twist Bioscience TWST
34.62
22. Qiagen QGEN
24.57
23. Trinity Biotech TRIB
22.52
24. Ortho Clinical Diagnostics Holdings OCDX
13.74
25. Heska HSKA
12.14
26. Co-Diagnostics CODX
-12.1
27. Inotiv NOTV
-16.5
28. Syneos Health SYNH
-16.98
29. Olink Holding OLK
-26.82
30. Anixa Biosciences ANIX
-27.95
31. NeoGenomics NEO
-33.71
32. Myriad Genetics MYGN
-39.8
33. CareDx CDNA
-40.51
34. Sera Prognostics SERA
-45.9
35. Exact Sciences EXAS
-49.97
36. Sotera Health SHC
-51.04
37. Neogen NEOG
-52.96
38. Bioventus BVS
-55.96
39. Illumina ILMN
-60.9
40. National Research NRC
-62.35
41. Guardant Health GH
-65.96
42. Pacific Biosciences of California PACB
-68.67
43. Enzo Biochem ENZ
-70.74
44. MaxCyte MXCT
-74.28
45. Psychemedics PMD
-75.31
46. Personalis PSNL
-76.77
47. MDxHealth MDXH
-78.6
48. bioAffinity Technologies BIAF
-79.4
49. Neuronetics STIM
-84.28
50. Interpace Biosciences IDXG
-85.31
51. Global Cord Blood CO
-86.47
52. Exagen XGN
-87.86
53. Biodesix BDSX
-88.08
54. Precipio PRPO
-91.26
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.49

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.